MetabolicIncretin analog
Semaglutide
GLP-1 analog / Ozempic / Wegovy / Rybelsus
- Peptide length
- 31 amino acids
Acylated peptide analog
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A long-acting GLP-1 receptor agonist used in regulated medicines. Oral and injectable products have different formulations and labeled uses.
- Family
- Incretin analog
- Primary research frame
- GLP-1 receptor
- Molecular format
- Acylated peptide analog
- Formula in linked record
- C187H291N45O59
Reading note
The supplied shortage chronology was outdated: FDA resolved the injectable semaglutide shortage in February 2025. Product labeling remains the source for indications and warnings.
Read the full record